1. Home
    /
  2. IPO
Chemkart India IPO

4.06x

subscribed

Chemkart India IPO

Hospital & Healthcare Services
listed
₹2.83LMin. investment
  1. Pre-apply
    5 Jul
  2. Bid start
    7 Jul
  3. Bid end
    9 Jul
  4. Allotment
    10 Jul
  5. Release of funds
    11 Jul
  6. Demat transfer
    11 Jul
  7. Listing
    14 Jul

Chemkart India Limited IPO Details

SectorHospital & Healthcare Services
Price range₹236 – ₹248
IPO type
SME
Lot size600 shares
Issue size₹80Cr
Red Herring Prospectus
Read
Market Cap
₹300.06CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹203.28CrLower than sector avg
Growth rate3Y CAGR
24.39%

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector
Apollo Hospitals Enterprise LtdApollo Hospitals Enterprise Ltd
Max Healthcare Institute LtdMax Healthcare Institute Ltd
Fortis Healthcare LtdFortis Healthcare Ltd
Revenue
Higher revenue means strong sales and good market demand
This IPO
₹203.28Cr
This sector
₹810.55Cr
Compare with companies
PAT
Higher PAT means strong profitability and efficient cost management
This IPO
₹24.26Cr
This sector
₹87.66Cr
Compare with companies
Market cap
Higher market cap means strong confidence but may suggest overvaluation
This IPO
₹300.06Cr
This sector
₹10,075.9Cr
Compare with companies
P/E ratio
Lower ratio usually means stock is undervalued
This IPO
9.71
This sector
55.14
Compare with companies
D/E ratio
Lower ratio usually means fewer liabilities
This IPO
0.32
This sector
0.40
Compare with companies

Objectives

Capital expenditure
57.45%
Repayment of loan
33.10%
General corporate purposes
9.45%

About Chemkart India Limited

Incorporated in 2020, Chemkart India Ltd is a Mumbai-based B2B nutraceutical firm offering various nutritional, health and sports supplement products. The company mainly targets business-to-business (B-to-B) platform which uses its products to manufacture finished supplements. Chemkart India offers ingredients across seven categories: amino acids, health supplements, herbal extracts, nucleotides, protein, sports nutrition, and vitamins, with Amino acids (44.4%), sports nutrition (29.1%), and health supplements 11.9%) leading its portfolio. It derives 99% of its revenue from domestic markets, with Maharashtra, Gujarat, and Haryana contributing 56.9% in FY25. It operates a 28,259 sq. ft. processing facility in Bhiwandi, generating ₹194.91 crore (95.88%) from trading and ₹8.37 crore (4.12%) from in-house processing. To enhance backward integration, Chemkart acquired 99% stakes in Easy Raw Materials and Vinstar Biotech.

Chemkart India IPO Subscription Status

Date
QIB
NII
Retail
Total
07-Jul-25
0.32 times (X)
1.1 times (X)
0.1 times (X)
0.36 times (X)
08-Jul-25
1.37X
1.58X
0.26X
1.01X
09-Jul-25
5.49X
5.12X
1.59X
4.06X

Frequently asked questions

How to invest in the Chemkart India IPO ?

Investors can apply for the Chemkart India IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Chemkart India IPO ?

The issue size of the Chemkart India IPO is 80 Cr.

What is 'pre-apply' for Chemkart India IPO ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Chemkart India IPO shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.